HCA’s third-quarter net income was $518 million, a sizeable increase over the $365 million it posted for the same quarter last year. In addition, HCA’s adjusted EBITDA totaled $1.83 billion compared to $1.60 billion in the third quarter of 2013.
The hospital operator’s strong financial results are partially attributable to an increase of 4.1 percent in same facility equivalent admissions, with revenue per admission increasing 3.8 percent.
“Results for the company’s third quarter reflect a continuation of solid volume trends and improving payer and service mix,” said R. Milton Johnson, president and CEO of HCA.
Based on its strong third-quarter financial results, HCA raised its previously issued financial guidance ranges for 2014. The hospital operator now predicts its revenues for 2014 will be between $36.50 billion and $37 billion, and its adjusted EBITDA will be between $7.25 billion and $7.35 billion for the year.
More articles on healthcare finance:
LifePoint reports strong Q3 financial results, expects trend to continue
For-profit hospital stock report: Week of Oct. 20-24
5 most-read finance stories: Week of Oct. 20-24
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
